CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children (2013)
- Authors:
- USP affiliated authors: KALIL FILHO, JORGE ELIAS - FM ; KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1097/QAD.0000000000000007
- Subjects: PROGRAMAS DE VACINAÇÃO; CRIANÇAS; VACINAS VIRAIS; ESTUDOS DE COORTES
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
MILAGRES, Lucimar G. et al. CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children. AIDS, n. 17, p. 2697-2705, 2013Tradução . . Disponível em: https://doi.org/10.1097/QAD.0000000000000007. Acesso em: 08 out. 2024. -
APA
Milagres, L. G., Costa, P. R., Santos, B. A. N., Silva, G. P., Cruz, A. C., Manfro, W. F. P., et al. (2013). CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children. AIDS, ( 17), 2697-2705. doi:10.1097/QAD.0000000000000007 -
NLM
Milagres LG, Costa PR, Santos BAN, Silva GP, Cruz AC, Manfro WFP, Ferreira B, Barreto DM, Frota ACC, Kalil Filho JE, Hofer CB, Kallás EG. CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children [Internet]. AIDS. 2013 ;( 17): 2697-2705.[citado 2024 out. 08 ] Available from: https://doi.org/10.1097/QAD.0000000000000007 -
Vancouver
Milagres LG, Costa PR, Santos BAN, Silva GP, Cruz AC, Manfro WFP, Ferreira B, Barreto DM, Frota ACC, Kalil Filho JE, Hofer CB, Kallás EG. CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children [Internet]. AIDS. 2013 ;( 17): 2697-2705.[citado 2024 out. 08 ] Available from: https://doi.org/10.1097/QAD.0000000000000007 - Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection
- Invariant natural killer T cells in patients with common variable immunodeficiency [Carta]
- Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
- CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
- IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID
- The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection
- Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
- Broad and Cross-clade CD4+ T-Cell responses elicited by a DNA vaccine encoding highly conserved and promiscous HIV-1 M-group consensus peptides
- Short Communication: HIV Type 1 Subtype BF Leads to Faster CD4+ T Cell Loss Compared to Subtype B
Informações sobre o DOI: 10.1097/QAD.0000000000000007 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas